Keyphrases
Rituximab
100%
Cardiac Tamponade
58%
Mepolizumab
58%
Hypereosinophilic Syndrome
58%
Altered Mental Status
58%
Acute Cerebellitis
58%
Anti-programmed Death 1
58%
Rituximab-refractory
58%
Subcutaneous Bortezomib
58%
Plasma Cell Leukemia
58%
Diagnostic Test
58%
Multiple Organ Dysfunction
58%
Chest Pain
58%
Indolent Lymphoma
58%
Single-hit Lymphoma
58%
Venetoclax
58%
Diffuse Large B-cell Lymphoma Cells
58%
Unclassifiable B-cell Lymphoma
58%
Pegfilgrastim
58%
Poor Prognosis
58%
Pneumonitis
58%
Lymphoma Patients
58%
Elderly Women
58%
Human Epidermal Growth Factor Receptor 2 (HER2)
58%
Phase II Trial
58%
Thrombotic Thrombocytopenic Purpura
58%
Women with Breast Cancer
58%
Unusual Cause
58%
Thrombospondin Type 1 Repeat
35%
Member 13
35%
Metalloprotease
35%
Disintegrin
35%
Fluorescence in Situ Hybridization
34%
Eosinophil Count
29%
Shortness of Breath
29%
Myopericarditis
29%
Diarrhea
29%
Dyspnea
29%
Tissue Infiltration
29%
Pericardial Fluid
29%
Coronary Artery
29%
Peripheral Blood
29%
Chest Imaging
29%
Pericardial Effusion
29%
Bronchoalveolar Lavage
29%
Eosinophils
29%
Overproduction
29%
Cardiac Enzymes
29%
Ejection Fraction
29%
Cardiac Catheterization
29%
Medicine and Dentistry
Rituximab
88%
Thrombotic Thrombocytopenic Purpura
58%
B-Cell Lymphoma
58%
Plasma Cell Leukemia
58%
Venetoclax
58%
Bortezomib
58%
Mepolizumab
58%
Cardiac Tamponade
58%
Mental Health
58%
Survival Rate
58%
Epidermal Growth Factor Receptor 2
58%
Breast Cancer
58%
Gamma Urogastrone
58%
Diffuse Large B-Cell Lymphoma
58%
Thorax Pain
58%
Immunotherapy
58%
Pneumonia
58%
Symptom
58%
Hypereosinophilic Syndrome
58%
Dyspnea
58%
Eosinophil
58%
Diagnosis
58%
Pericardial Fluid
58%
Multiple Myeloma
39%
Disease
39%
Thrombospondin
35%
Plasma Exchange
35%
Disintegrin
35%
Metalloproteinase
35%
Fluorescence in Situ Hybridization
32%
Vincristine
29%
Prednisone
29%
Chest Imaging
29%
Pediatrics
29%
Progression Free Survival
29%
Overall Survival
29%
Magnetic Resonance Imaging
29%
Cyclophosphamide
29%
Doxorubicin
29%
Diarrhea
29%
Coronary Artery
29%
Eosinophilic
29%
Outpatient
29%
Glucocorticoid
29%
Cardiac Catheterization
29%
Lung Lavage
29%
Pericardiocentesis
29%
Ejection Fraction
29%
Nonsteroid Antiinflammatory Agent
29%
Neoplasm
24%